Article

Effective Doses in Radiology and Diagnostic Nuclear Medicine: A Catalog 1

Department of Radiology and Nuclear Medicine, New Mexico Veterans Administration Healthcare System, 1501 San Pedro Blvd, Albuquerque, NM 87108, USA.
Radiology (Impact Factor: 6.87). 08/2008; 248(1):254-63. DOI: 10.1148/radiol.2481071451
Source: PubMed

ABSTRACT

Medical uses of radiation have grown very rapidly over the past decade, and, as of 2007, medical uses represent the largest source of exposure to the U.S. population. Most physicians have difficulty assessing the magnitude of exposure or potential risk. Effective dose provides an approximate indicator of potential detriment from ionizing radiation and should be used as one parameter in evaluating the appropriateness of examinations involving ionizing radiation. The purpose of this review is to provide a compilation of effective doses for radiologic and nuclear medicine procedures. Standard radiographic examinations have average effective doses that vary by over a factor of 1000 (0.01-10 mSv). Computed tomographic examinations tend to be in a more narrow range but have relatively high average effective doses (approximately 2-20 mSv), and average effective doses for interventional procedures usually range from 5-70 mSv. Average effective dose for most nuclear medicine procedures varies between 0.3 and 20 mSv. These doses can be compared with the average annual effective dose from background radiation of about 3 mSv.

Download full-text

Full-text

Available from: Terry Yoshizumi, Nov 16, 2015
  • Source
    • "The amount of radiation from a CTPA varies by machine, protocol, and patient characteristics such as patient size, but radiation levels between 10 and 20 mSv are considered typical [3]. This corresponds to three to five year's background radiation or the equivalent of approximately 750 chest X-rays [3]. The overall risk may be small but for certain patient groups such "
    [Show abstract] [Hide abstract]
    ABSTRACT: Aims. To study the use of CT pulmonary angiography (CTPA) at Hutt Hospital and investigate the use of pretest probability scoring in the assessment of patients with suspected pulmonary embolism (PE). Methods. We studied patients with suspected PE that underwent CTPA between January and May 2012 and collected data on demographics, use of pretest probability scoring, and use of D Dimer and compared our practice with the British Thoracic Society (BTS) guideline. Results. 105 patients underwent CTPA and 15% of patients had PE. 13% of patients had a Wells score prior to their scan. Wells score calculated by researchers revealed 54%, 36%, and 8% patients had low, medium, and high risk pretest probabilities and 8%, 20%, and 50% of these patients had positive scans. D Dimer was performed in 58% of patients and no patients with a negative D Dimer had a PE. Conclusion. The CTPA positive rate was similar to other contemporary studies but lower than previous New Zealand studies and some international guidelines. Risk stratification of suspected PE using Wells score and D Dimer was underutilised. A number of scans could have been safely avoided by using accepted guidelines reducing resources use and improving patient safety.
    Full-text · Article · Nov 2015
    • "Although no well-controlled human studies have been conducted to evaluate the teratogenic effect of gadolinium in pregnant women, no harmful effects have been reported for human fetuses exposed to gadolinium in utero. Different studies have demonstrated that the fetus can excrete, swallow, and reabsorb gadolinium into the gastrointestinal tract, which persists in the amniotic fluid (Mettler et al., 2008). Therefore, in clinical practice, it is wise to consider the use of gadolinium-based contrast media in pregnant women only when the "
    [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND Traditionally, pregnancy was considered to have a positive effect on endometriosis and its painful symptoms due not only to blockage of ovulation preventing bleeding of endometriotic tissue but also to different metabolic, hormonal, immune and angiogenesis changes related to pregnancy. However, a growing literature is emerging on the role of endometriosis in affecting the development of pregnancy and its outcomes and also on the impact of pregnancy on endometriosis. The present article aims to underline the difficulty in diagnosing endometriotic lesions during pregnancy and discuss the options for the treatment of decidualized endometriosis in relation to imaging and symptomatology; to describe all the possible acute complications of pregnancy caused by pre-existing endometriosis and evaluate potential treatments of these complications; to assess whether endometriosis affects pregnancy outcome and hypothesize mechanisms to explain the underlying relationships.
    No preview · Article · Oct 2015 · Human Reproduction Update
  • Source
    • "However, in clinical practice, the American College of Radiology (ACR) Manual on Contrast Media recommends the use of intravenous iodinated contrast agent only in pregnant patients when necessary [12] [15]. The largely increased use of CT in pregnant patients due to its value as a rapid diagnostic tool in acute or critical disease may avoid delay, and therefore it may improve maternal and fetal morbidity and mortality [16] [17]. However, as pregnant patients undergo treatment, response assessment by additional (contrastenhanced ) CT scans may lead to inacceptable cumulative radiation and contrast doses. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Diagnosis and staging of cancer during pregnancy may be difficult due to overlap in physical signs, uncertainties on safety and accuracy of diagnostic tests and histopathology in pregnant women. Tumour markers should be used with caution due to pregnancy-induced elevation. Ionizing imaging and staging techniques such as computed tomography (CT) or positron emission tomography (PET) scans and sentinel node procedures are safe during pregnancy when fetal radiation threshold of 100 mGy is maintained. Ionizing imaging techniques can increasingly be avoided with the technical devolvement of non-ionizing techniques such as magnetic resonance imaging (MRI), including whole body MRI and diffusion-weighted imaging, which hold potentially great opportunities for the diagnostic management of pregnant cancer patients. Pathological evaluation and establishing a diagnosis of malignancy can be difficult in pregnant women, and a note to the pathologist of the pregnant status is essential for accurate diagnosis. This chapter will give an overview of possibilities and difficulties in diagnosing pregnant women with cancer.
    Full-text · Article · Oct 2015 · Best practice & research. Clinical obstetrics & gynaecology
Show more